ARID2 and neoplasm: In fact, within the 276 fully shared mutations (Dataset EV1), we found genetic lesions in the oncogene NTRK1 and the tumor suppressors TP53, ARID2, SMARCA4, ZFHX3, all of which have been described in CUPs (Zehir et al, 2017).